The effect of growth hormone therapy on growth and mental development in children with Down sydrome

Developmental Brain Dysfunction

Volumn 9, Issue 2-3, 1996, Pages 138-143

  Anneren G ^a   Carlsson Skwirut, C ^b   Sara, V R ^b   Tuvemo, T ^a   Gustafsson, J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Down syndrome; Growth hormone therapy; Growth retardation; Mental development

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GROWTH RETARDATION; HUMAN; INFANT; MALE; MENTAL DEVELOPMENT; PRESCHOOL CHILD;

EID: 0030057247     PISSN: 10195815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cronk C, Crocker AC, Pueschel SM, Shea AM, Zackai E, Pickens G, Reed RB: Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 1988;81:102-110.
2. Sara VR, Gustavson K-H, Annerén G, Hall K, Wetterberg L: Somatomedins in Down's syndrome. Biol Psychiatry 1983;18:803-811.
3. Milunsky A, Lowy C, Rubenstein A, Wright AD: Carbohydrate tolerance, growth hormone and insulin levels in mongolism. Dev Med Child Neurol 1968;10:25-31.
4. Ruvalcaba RHA, Thuline HC, Kelley VC: Plasma growth hormone in patients with chromosomal anomalies. Arch Dis Child 1972;47:307-309.
5. Annerén G, Sara VR, Hall K, Tuvemo T: Growth and somatomedin responses to growth hormone in Down's syndrome. Arch Dis Child 1986;61:48-52.
6. Castells S, Torrado C, Bastian W, Wisniewski KE: Growth hormone deficiency in Down's syndrome children. J Intellect Disabil Res 1992;36:29-43.
7. Annerén G, Engberg G, Sara VR: The presence of normal levels of serum immunoreactive insulin-like growth factor 2 (IGF-2) in patients with Down's syndrome. Ups J Med Sci 1984;89:274-278.
8. Sara VR, Sjögren B, Annerén G, Gustavson K- H, Forsman A, Hall K, Wahlström J, Wetterberg L: The presence of normal receptors for somatomedin and insulin in fetuses with Down's syndrome. Biol Psychiatry 1984;19:591-598.
9. Annerén G, Gustafsson J, Sara VR, Tuvemo T: Normalized growth velocity in children with Down's syndrome during growth hormone therapy. J Intellect Disabil Res 1993;37:381-387.
10. Johansson I: Teaching prereading skills to disabled children. J Intellect Disabil Res 1993;37:413-417.
11. Greulich WW, Pyle SJ: Radiographic Atlas of the Skeletal Development of Hand and Wrist. Stanford, Stanford University Press, 1959.
12. Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H: Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method), ed 2. London, Academic Press, 1993.
13. Holle B, Bonnelycke K, Kemp E, Thrane-Mortensen L: Motorisk-Perceptuell utveckling. Protokoll 0-7 år. Eskilstuna, Psykologiförlaget AB, 1984.
14. Alin-Åkerman B, Nordberg L: Griffiths' utvecklingskalor I och II. Manual för administrering och utvärdering. Eskilstuna, Psykologiförlaget AB, 1984.
15. Karlberg P, Taranger J, Engström J, Landström T, Lichtenstein H, Lindström B, Svennberg-Redegren I: Physical growth from birth to 16 years and longitudinal outcome of the study during the same period. Acta Pediatr Scand 1976 (suppl 258).
16. Carr J: Six weeks to twenty-one years old: Longitudinal study of children with Down's syndrome and their families. J Child Psychol Psychiatry 1988;29:407-431.
17. Pozsinyi J, Gibson D, Zarfas DE: Skeletal maturation in mongolism (Down's syndrome). J Pediatr 1964;64:75-78.
18. Torrado C, Bastian W, Wisniewski KE, Castells S: Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone. J Pediatr 1991;119:478-483.
19. Sara VR, Hall K, Rutter M, Wetterberg L, Yuwiler A: Hormonal regulation of brain growth: Implication for mental retardation; in Perris C, Struwe G, Jansson B (eds): Biological Psychiatry. Amsterdam, North Holland, Elsevier, 1981, pp 1319.
20. McGauley GA: Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Pediatr Scand Suppl 1989;356:70-72.
21. Annerén G, Bull M, Flórez J, Guyda HJ, Mortimer J, Pueschel SM: Statement for parents on growth hormone treatment for children with Down syndrome. 1994 International Down Syndrome Research Conference, National Down Syndrome Society, Charleston, April 10-13, 1994, in press.
22. Allen DB, Fraiser SD, Foley TP Jr, Pescovitz OH: Growth hormone for children with Down syndrome (editorial). J Pediatr 1993;123:742-743.